| SCYX Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the SCYX market cap history going back to 8/1/2014:
Also see: SCYX Shares Outstanding History and SCYX YTD Return |
SCYX Market Cap History — SCYNEXIS Capitalization Over Time
As of 5/1/2026 SCYNEXIS has a market cap of 78.65 million. Investors often follow the SCYX market cap history to compare the size of the company over time.
This page shows SCYX market capitalization trends over time, with 37 market cap datapoints presented, dating back to 8/1/2014.
| SCYX Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
SCYX Historical Market Cap: +2.59% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| SCYX Stock Price Chart |
| About SCYNEXIS, Inc. |
| SCYNEXIS, Inc. is a biotechnology company. It is pioneering medicine to overcome and prevent difficult-to-treat and drug-resistant infections. It develops antifungal platform fungerps, a novel class of antifungal agents called triterpenoids, that are structurally distinct glucan synthase inhibitors and have generally shown in vitro and in vivo activity against a range of human fungal pathogens, such as Candida and Aspergillus genera, including multidrug-resistant strains, and Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and common mucorales species. We show 37 historical shares outstanding datapoints in our SCYX shares outstanding history coverage, used to compute SCYX market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing SCYX market cap history over the course of time is important for investors interested in comparing SCYX's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of SCYX versus a peer is one thing; comparing SCYX market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like SCYX can fluctuate over the course of history. With this page we aim to empower investors researching SCYX by allowing them to research the SCYX market cap history. |
| SCYX Current Stock Quote |
Quotes delayed 20 minutes  Free SCYX Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: The Importance of Market Cap | |
|
Video: The Importance of Market Cap
| SCYX Share Performance |
| Market Cap Peers |
| SCYNEXIS (SCYX) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
SDC Market Cap History SDGR Market Cap History SEEL Market Cap History SEER Market Cap History SELB Market Cap History SEM Market Cap History SENS Market Cap History SERA Market Cap History SESN Market Cap History SGEN Market Cap History More Healthcare companies » |
SCYX Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
